Andrew B. Herson

Andrew B. Herson

Auto-generated profile, based on publicly available information

Andrew B. Herson

Department of Internal Medicine , University of South Florida Morsani College of Medicine , Tampa , Florida , USA , usf.edu

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2023 in Cureus
Verified
Journal Article
Open access
PDF file
AHAndrew B. Herson
Andrew B. Herson
JSJohn M. Sousou
John M. Sousou
KBKimberly Boldig
Kimberly Boldig
FPFalguni Patel
Falguni Patel
PRPramod Reddy
Pramod Reddy
Kaposi's sarcoma (KS) is an Acquired Immune Deficiency Syndrome (AIDS)-defining illness, with cutaneous KS being a more common presentation. Visceral involvement, particularly in the gastrointestinal (GI) tract, without cutaneous involvement, is rare. Consisting of generally non-specific symptoms, GI-KS can have potentially fatal outcomes, including hemorrhage or perforation, making prompt diagnosis and treatment imperative. Our case describes a 31-year-old male with AIDS who presented with a neck mass and purulent, bloody rectal drainage. The neck mass was biopsied and identified as caseated necrotic cervical lymphadenitis caused by Mycobacterium avium complex (MAC). The patient presented with rectal drainage, and additional abdominal necrotic lymph nodes were discovered on CT. A subsequent colonoscopy was completed, confirming the diagnosis of visceral KS. Delayed diagnosis of visceral KS can lead to an extensive, widespread disease requiring adjuvant and prolonged treatment. Prompt diagnosis can reduce morbidity and mortality. This case aims to shed light on a rare presentation of a common disease state with potentially fatal complications and emphasizes the importance of maintaining a broad differential diagnosis.

1 January 2026 in Case Reports in Cardiology
Verified
Journal Article
Open access
PDF file
CBCatherine Boldig
Catherine Boldig
AHAndrew Herson
Andrew Herson
JFJustin Falk
Justin Falk
MBMitchell Boshkos
Mitchell Boshkos
DRDAVID Z ROSE
DAVID Z ROSE
Ponatinib is a third‐generation BCR:ABL1 tyrosine kinase inhibitor used in selected patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph+ ALL), particularly those with T315I mutations, or disease resistant, or those intolerant to prior tyrosine kinase inhibitors. Although effective, ponatinib has been associated with arterial occlusive events. We report a 63‐year‐old man with Ph+ ALL who, while receving ponatinib, developed a myocardial infarction requiring quadruple coronary artery bypass grafting, followed by symptomatic intracranial arterial stenosis necessitating superficial temporal artery to middle cerebral artery bypass. Despite multiple cardiovascular risk factors, the chronology of progressive coronary and cerebral vascular disease raised suspicion for ponatinib‐associated vasculopathy, although causality cannot be established. To our knowledge, this is the first reported case of sequential coronary and cerebral surgical revascularization occurring during ponatinib therapy. This case highlights the importance of careful cardiovascular surveillance, multidisciplinary management, and individualized risk‐benefit assessment in patients treated with ponatinib.